High-Power, Short-Duration Ablation in Treatment of Patients With Atrial Fibrillation - Trial NCT06415149
Access comprehensive clinical trial information for NCT06415149 through Pure Global AI's free database. This phase not specified trial is sponsored by People's Friendship University of Russia and is currently Completed. The study focuses on Atrial Fibrillation. Target enrollment is 185 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
People's Friendship University of Russia
Timeline & Enrollment
N/A
Feb 01, 2022
Mar 01, 2024
Primary Outcome
interoperative outcomes,blinded period
Summary
20-45% of patients experience recurrence of atrial fibrillation (AF) after catheter ablation.
 The aim of this study was to evaluate efficiency and safety of high power short duration
 ablation in patients with atrial fibrillation and the clinical and procedural factors
 associated with the recurrence of AF in patients after HPSD ablation.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06415149
Non-Device Trial